XAIRA Trademark

Trademark Overview


On Friday, March 29, 2024, a trademark application was filed for XAIRA with the United States Patent and Trademark Office. The USPTO has given the XAIRA trademark a serial number of 98476104. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Saturday, March 30, 2024. This trademark is owned by Orion Medicines, Inc.. The XAIRA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical therapeutics, pharmaceutical preparations, medical therapeutics, and medical preparations in the fields of oncology, infectious disease, virology, cardiology, allergy, immunology, rheumatology, endocrinology, pulmonology, gastroenterology, and dermatology

Pharmaceutical research and development services; Scientific and medical research in the field of pharmaceutical development; Artificial intelligence, machine learning, and related services for life sciences and pharmaceutical development; Research and development of technology in the field of pharmaceuticals; Development of pharmaceutical preparations and medicines; Drug development and discovery; Biomedical research and development services; Pharmaceutical research and development services, namely, arranging and providing for clinical trials
xaira

General Information


Serial Number98476104
Word MarkXAIRA
Filing DateFriday, March 29, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateSaturday, March 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical therapeutics, pharmaceutical preparations, medical therapeutics, and medical preparations in the fields of oncology, infectious disease, virology, cardiology, allergy, immunology, rheumatology, endocrinology, pulmonology, gastroenterology, and dermatology
Goods and ServicesPharmaceutical research and development services; Scientific and medical research in the field of pharmaceutical development; Artificial intelligence, machine learning, and related services for life sciences and pharmaceutical development; Research and development of technology in the field of pharmaceuticals; Development of pharmaceutical preparations and medicines; Drug development and discovery; Biomedical research and development services; Pharmaceutical research and development services, namely, arranging and providing for clinical trials

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 29, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code7 - Inactive - Insufficient fee received
Class Status DateFriday, March 29, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameXAIRA THERAPEUTICS, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressSAN FRANCISCO, CA 94108

Party NameOrion Medicines, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94108

Trademark Events


Event DateEvent Description
Saturday, March 30, 2024NEW APPLICATION ENTERED
Sunday, September 1, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 20, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP